Vaginal Dryness and Urinary Symptoms After Menopause

You notice that sitting through a long meeting has become uncomfortable, sex hurts, or you are suddenly planning every trip around a bathroom. These symptoms are easy to leave out of an appointment. They may also be the symptoms most worth bringing up. Saying “vaginal dryness” at normal volume is allowed; the body part is not a secret.

The plain version: changes in estrogen can affect the vulva, vagina and urinary tract during and after menopause. Dryness, irritation, pain with penetration and some urinary symptoms can be treated. A lubricant or moisturizer may help mild symptoms; local prescription treatments, including low-dose vaginal estrogen, have stronger evidence for persistent symptoms. New bleeding, infection symptoms or unexplained pain should be assessed rather than assumed to be menopause.

What’s going on

The term genitourinary syndrome of menopause, or GSM, groups symptoms involving the labia and vaginal opening, vaginal tissue, urethra and bladder that can accompany lower estrogen levels [1] [5]. The term is long because it covers more than dryness. Tissue can become thinner, less elastic and more easily irritated. Some people notice burning or pain with penetration; others notice urgency or recurrent urinary concerns. You do not need to have every symptom to deserve care.

Unlike a hot flash, which may eventually fade, these symptoms do not necessarily improve just because more time passes. They can persist or worsen without treatment. That makes “wait it out” a particularly poor plan when the problem is affecting everyday comfort. The Menopause Society’s 2020 position statement described GSM as common and undertreated, with effective treatment available in many cases [1]. The 2025 AUA/SUFU/AUGS guideline treats it as a condition to identify and manage, not a normal inconvenience to ignore [2].

The affected tissue is not a single interchangeable surface. A lubricant reduces friction during sexual activity. A moisturizer is used regularly to address dryness between activities. Local estrogen acts on estrogen-responsive tissue. Those tools have different jobs. If the symptom is pain deep in the pelvis, a skin lesion or a urinary infection, the right answer may be something else entirely. This is why an examination can be more useful than trying a sixth product in private.

Urinary symptoms deserve their own description. More frequent trips to the bathroom, urgency and recurrent infections are different problems, even though they may occur together. A urine test can be useful when infection is suspected; a negative test may push the discussion toward bladder function, tissue changes or another cause. Do not assume every episode of burning is a urinary tract infection, and do not assume every urinary symptom is GSM. The point of naming the syndrome is to make care more precise, not to create a large box into which every symptom is dropped.

Is it the change, or something else?

Symptom	Can fit GSM	Other possibilities	Ask promptly about
Dryness or burning	Tissue changes around menopause	Infection, irritants, vulvar skin disease	Sores, new discharge or persistent unexplained pain
Pain with penetration	Friction and fragile tissue	Pelvic-floor muscle pain, infection, other pelvic conditions	Bleeding with sex or pain that is severe or new
Urgency or frequency	Urinary tract can be affected	Urinary infection, diabetes, bladder conditions	Fever, flank pain or blood in urine
Spotting	Fragile tissue may bleed	Cervical or uterine causes	Any bleeding after 12 months without a period

The last row deserves emphasis. Postmenopausal bleeding is not something to diagnose as “just dryness” yourself. It needs evaluation even if local tissue appears fragile. The same goes for new pain or infection symptoms. A clinician can check for a cause and still treat GSM if it is also present.

What helps, and how well

Moisturizers and lubricants. For mild symptoms, a vaginal moisturizer used regularly can improve comfort, while lubricant can reduce friction during sexual activity [1] [3]. They do not require a decision about systemic hormones. They also do not treat every cause of pain or urinary frequency. If a product stings or worsens irritation, stop using it and ask about alternatives rather than deciding your body is the problem.

Local vaginal estrogen. Low-dose vaginal estrogen is an effective treatment for persistent GSM symptoms and is distinct from systemic estrogen used for hot flashes [1] [6]. It is available in different local forms, which a clinician can discuss without turning the appointment into a brand comparison. Low-dose local treatment generally has much less whole-body exposure than systemic therapy. It is not a treatment for night sweats, so a person with both symptoms may need two separate decisions.

Other prescription choices. The 2020 position statement also discusses vaginal DHEA and an oral selective estrogen-receptor modulator for certain vulvovaginal symptoms [1]. They have different indications, contraindications and availability. You should not infer from the word nonhormonal that an oral medication is automatically lower risk for you than a local one. Ask which symptom a treatment is approved to address and what evidence supports that choice.

A history of breast cancer. ACOG recommends nonhormonal methods first for people with a history of estrogen-dependent breast cancer. If those are inadequate, it describes a shared decision about low-dose vaginal estrogen, involving the relevant clinicians and taking treatment history into account [4]. That is a more careful answer than either “never” or “always safe.” If you are taking an endocrine therapy, say which one. Your oncology team should be part of the conversation rather than left to discover the treatment later.

Energy-based devices. Vaginal lasers and similar devices are marketed with considerable confidence. The Menopause Society’s 2020 statement found too few adequate placebo-controlled trials to recommend them for GSM [1]. An expensive intervention should clear a higher evidence bar than a collection of before-and-after testimonials. A machine is not a substitute for a diagnosis.

How strong is the evidence? Local estrogen and several other established therapies have evidence for GSM, while moisturizers and lubricants are practical first steps for milder symptoms. The evidence is weaker or insufficient for marketed energy-based treatments. Long-term safety questions differ by treatment and are especially important for people with a cancer history. An individual assessment remains part of good care, not an obstacle placed in front of it.

What a useful visit sounds like

Start with the symptom in concrete terms: “The vaginal opening burns after I walk,” “penetration hurts enough that I avoid it,” or “I get up to urinate three times most nights.” You do not need to frame every complaint around sex. If sex is relevant, say what kind of contact hurts and where. If it is not relevant, the symptom still counts. The clinician can then ask about timing, medicines, infection signs, skin changes, bleeding and bladder symptoms.

It is reasonable to ask for an examination if symptoms are new or persistent. An examination can identify a visible skin condition, signs of infection or a source of bleeding. It can also help the clinician explain why a particular treatment fits. You can ask the purpose of each part and discuss comfort. The goal is information and relief, not an endurance test.

Choose a follow-up point. If you try a moisturizer, decide what improvement would be meaningful and when to discuss next steps. If a prescription treatment is chosen, ask what symptoms it should improve and which symptoms would still need separate assessment. Pain deserves a plan; a vague instruction to “use more lubricant” is incomplete if it has already failed.

If you have avoided the subject because an earlier visit felt dismissive, say that plainly if you can. “I was told this was normal, but it still hurts” gives the next clinician important context. You can bring written notes or ask for a clinician comfortable discussing genitourinary symptoms. The aim is a specific diagnosis and an agreed trial of care. Embarrassment is common, but you do not need to earn treatment by proving the symptom is severe enough for someone else.

If penetration hurts, avoiding it while you seek help is a reasonable response to pain, not a treatment failure. Ask whether pelvic-floor muscle tension, skin changes or another source of pain should be evaluated in addition to dryness. If a treatment improves tissue comfort but pain persists, that is a clue to revisit the diagnosis rather than simply using more of the same product. The goal is comfortable function on your terms, whether or not sexual activity is part of your life.

The same principle applies to urinary symptoms. If urgency improves but infections keep returning, or if a presumed infection is repeatedly treated without testing, ask for the pattern to be reviewed. A clinician can consider local tissue treatment, bladder assessment and other causes. “This happens at your age” is a description of prevalence. It is not a plan for the next bathroom trip.

Take this to your appointment

• “My main symptom is [dryness / burning / pain / urgency]. Can we check whether GSM fits and whether another condition needs treatment?”
• “Would a moisturizer or lubricant be enough, or is a local prescription treatment more likely to help?”
• “How is low-dose vaginal estrogen different from systemic hormone therapy in my case?”
• “I have a history of [cancer or other condition]. Who should be involved in this decision?”
• “What should improve, and when should I return if it does not?”

See a clinician promptly if… you have any bleeding after 12 months without a period, very heavy or prolonged bleeding, new chest pain, a painful swollen leg or sudden shortness of breath, or low mood that won’t lift. If you are thinking about harming yourself, call or text 988 in the US, or call 911 in an emergency. This article is general education, not medical advice.

For the wider treatment distinction, read hormone therapy risks explained and perimenopause signs.